Tag: resectable

Health Canada Authorizes Perioperative Pembrolizumab in Resectable, Locally Advanced HNSCC
Head and Neck Healthcare

Health Canada Authorizes Perioperative Pembrolizumab in Resectable, Locally Advanced HNSCC

August 27, 2025
admin

Head and neck squamous cell carcinoma | Image Credit: Lars Neumann © – stock.adobe.com Health Canada…

Continue Reading
FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression
Head and Neck Healthcare

FDA approves pembrolizumab for resectable head and neck cancer with PD-L1 expression

June 17, 2025
admin

Credit: Unsplash/CC0 Public Domain Pembrolizumab, an immune checkpoint inhibitor, has been approved by the U.S. Food…

Continue Reading